URSULA HOXIE: Open Payments
NPI 1477929420 · WALLINGFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,511 in 107 payments from 18 companies in 2025. Trend: 2023 $3,077 · 2024 $2,641 · 2025 $2,511
Food & beverage: $2,511
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 23 | $433 |
| ViiV Healthcare Company | 12 | $318 |
| Axsome Therapeutics, Inc. | 14 | $271 |
| Janssen Pharmaceuticals, Inc | 8 | $196 |
| Lilly USA, LLC | 8 | $190 |
| Lundbeck LLC | 6 | $170 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $150 |
| MERZ NORTH AMERICA, INC. | 1 | $144 |
| Alkermes, Inc. | 6 | $137 |
| Astellas Pharma US Inc | 4 | $105 |
Products named: SUBLOCADE, APRETUDE, Sunosi, SPRAVATO, REXULTI, MOUNJARO, Xeomin, VIVITROL.
Industry payments across CT — which companies pay providers there.
